Treatment for chronic myeloid leukaemia (CML)
For some people it is safe to stop treatment if their chronic myeloid leukaemia (CML) is under control.
Your doctor can talk with you about whether a treatment break might be an option for you.
You usually take TKI drugs every day, for as long as it is controlling your leukaemia. You carry on taking it even if your tests don’t show any signs of leukaemia.
Researchers have been doing trials to see if it is safe to stop TKI treatment. This is called a treatment break. Or your doctor might call it treatment free remission.
Clinical trials show that it is safe for some people to stop their TKIs if they have been:
on TKIs for around five years
in remission for a long time - this means that tests have not shown any signs of leukaemia for at least 2 years (a deep molecular response)
Read about monitoring your treatment response
Your doctor will talk to you about this when you start treatment. There are different reasons why you might want to try and have a break. And it is more suitable for some people than others.
For example, some people want a break from treatment because they have been having some side effects from the drug.
It might also be an option for some women who want to start a family. It might be possible to plan for a treatment break so they have the opportunity to try and get pregnant.
Your doctor might suggest you have a treatment break if:
you have been taking TKIs for at least 3 to 5 years
you have not had accelerated or blast phase leukaemia
you have had a very good response to treatment which has lasted for at least 2 years
you don’t have any extra chromosomal abnormalities – your doctor will talk to you about this
your hospital has a laboratory that can provide the blood tests you need
you are keen to have a break, you understand what it involves, and you are willing to have all the extra blood tests to monitor your CML
Your doctor might suggest reducing your dose of TKI for around 12 months before you stop completely. Or you might stop taking the TKI straight away.
You might have some side effects when you stop taking TKIs. Doctors call this withdrawal syndrome. Side effects include:
aching muscles and joints
feeling unwell
These symptoms are usually mild and pass quickly. Your doctor might suggest you take . Rarely, you might need to restart taking TKIs.
Your doctor will continue to look for signs of leukaemia in your blood when you stop the treatment. You have a regular PCR blood test to do look for the BCR-ABL1 gene.
After you stop treatment you might have PCR tests:
monthly for the first 6 months
every 6 weeks to 2 months for the next 6 months
every 2 to 3 months after that
If your CML does come back, it is most likely to come back in the first 6 months after you stop treatment. The rest of the people who need to restart treatment, usually do so within the first 2 years. It is less common to need to restart after 2 years, although this can happen.
Your doctors will continue to monitor you closely.
Read more about tests to monitor CML
Your doctor will recommend you start treatment again if tests start to detect the BCR-ABL1 gene. This is a sign that your CML is coming back.
You restart TKI treatment if the doctors think your CML has come back. You usually restart the same drug as you were on before the treatment break. Or you might go on a different drug if you had side effects.
Your doctor does a blood test every 4 weeks to look for signs of leukaemia, until you go back into remission. The vast majority of people have a very good response when they restart the treatment. This means that after taking the TKI treatment again, the tests no longer show any signs of leukaemia. You are very likely to go back into remission.
You might be able to try a second break in treatment if you have another good response to the treatment.
Last reviewed: 23 Jun 2025
Next review due: 23 Jun 2028
Targeted cancer drugs called tyrosine kinase inhibitors (TKIs) are the main treatment for CML. Find out more about your treatment options, the different treatments and how they monitor treatment is working.
You have regular tests during treatment to look for signs of CML. The test results find out how well the treatment is working. Find out more.
Chronic myeloid leukaemia (CML) is often a slowly developing condition. Treatment can keep it under control for many years. Find out how to cope and what support is available.
CML starts in the white blood cells called granulocytes. It often develops slowly and treatment can keep it under control for many years. Find out more.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.